NEW YORK and BERLIN, Aug. 01, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, plans to announce its second quarter 2022 financial results and business update on Monday, August 15, 2022. A video interview with atai management will be available at 8:30 a.m. (ET) at https…


Previous articleBREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics
Next articleBraxia Scientific Reports Fourth Quarter and FY 2022 Financial Results